Cosmo Pharmaceuticals announces revolutionary Artificial Intelligence device in colonoscopy to detect lesions and worldwide distribution agreement with Medtronic
Cosmo Pharmaceuticals NV today announced that it has developed a revolutionary artificial intelligence (AI) software and device for the detection of lesions during colonoscopy and has entered into a worldwide distribution agreement with Medtronic, the global leader in medical technology.